1. Home
  2. PRO vs IMNM Comparison

PRO vs IMNM Comparison

Compare PRO & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRO
  • IMNM
  • Stock Information
  • Founded
  • PRO 1985
  • IMNM 2006
  • Country
  • PRO United States
  • IMNM United States
  • Employees
  • PRO N/A
  • IMNM N/A
  • Industry
  • PRO EDP Services
  • IMNM Medicinal Chemicals and Botanical Products
  • Sector
  • PRO Technology
  • IMNM Health Care
  • Exchange
  • PRO Nasdaq
  • IMNM Nasdaq
  • Market Cap
  • PRO 863.3M
  • IMNM 748.3M
  • IPO Year
  • PRO 2007
  • IMNM 2020
  • Fundamental
  • Price
  • PRO $15.57
  • IMNM $8.98
  • Analyst Decision
  • PRO Strong Buy
  • IMNM Strong Buy
  • Analyst Count
  • PRO 10
  • IMNM 5
  • Target Price
  • PRO $28.50
  • IMNM $26.40
  • AVG Volume (30 Days)
  • PRO 1.1M
  • IMNM 828.5K
  • Earning Date
  • PRO 07-29-2025
  • IMNM 08-11-2025
  • Dividend Yield
  • PRO N/A
  • IMNM N/A
  • EPS Growth
  • PRO N/A
  • IMNM N/A
  • EPS
  • PRO N/A
  • IMNM N/A
  • Revenue
  • PRO $336,006,000.00
  • IMNM $10,938,000.00
  • Revenue This Year
  • PRO $10.25
  • IMNM N/A
  • Revenue Next Year
  • PRO $10.46
  • IMNM $310.65
  • P/E Ratio
  • PRO N/A
  • IMNM N/A
  • Revenue Growth
  • PRO 7.97
  • IMNM N/A
  • 52 Week Low
  • PRO $13.61
  • IMNM $5.15
  • 52 Week High
  • PRO $29.84
  • IMNM $16.81
  • Technical
  • Relative Strength Index (RSI)
  • PRO 38.63
  • IMNM 48.90
  • Support Level
  • PRO $13.61
  • IMNM $8.46
  • Resistance Level
  • PRO $20.28
  • IMNM $9.11
  • Average True Range (ATR)
  • PRO 0.83
  • IMNM 0.49
  • MACD
  • PRO -0.20
  • IMNM -0.10
  • Stochastic Oscillator
  • PRO 20.69
  • IMNM 28.75

About PRO PROS Holdings Inc.

Pros Holdings Inc provides software solutions that optimize shopping and selling experiences for both business-to-business and business-to-consumer companies across industry verticals in more than nearly 80 countries. Its PROS Platform is designed to help businesses create, optimize and market available offers and handle orders through both first- and third-party digital channels. The firm generates key revenue form the United States of America, Germany, The rest of Europe, Africa, Asia-Pacific, and Middle East regions.

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Share on Social Networks: